It may be time to ditch the stepwise approach and embrace combination therapy in treating type 2 diabetes, said James R. Gavin III, MD, PhD, at CRS 2018.
Previous evidence has suggested a complex relationship between OSA and diabetes, but to date, no population-based study has evaluated the potential bidirectional association between the 2 disorders.
Consultant360 spoke with Dr Jeffrey Scherrer from St Louis University School of Medicine about his new study, which explored the effect modification of obesity on the association between posttraumatic...
Although excess mortality risk is common in patients with diabetes, it is less well understood how the presence of common comorbidities affects this risk.
In more than 2700 patients with type 2 diabetes and poor glycemic control, researchers investigated potential predictors of achieving glycemic goals at 6 and 12 months.
In a new study, researchers compared outcomes among more than 77,000 metformin initiators who either remained on metformin, added sulfonylureas to metformin, or switched entirely to sulfonylureas.
Adolescents with type 1 diabetes are known to have an increased risk for psychosocial comorbidities, including anxiety and depression. With this in mind, researchers sought to further explore the impact of...
DPP-4 inhibitors are often discontinued upon initiation of insulin therapy in patients with type 2 diabetes. However, new research presented in at the ADA’s 78th Scientific Sessions has suggested that...
